• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines Triazinones

Introduction to 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)- (CAS No. 1548574-54-4)

The compound 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)-, identified by its CAS number 1548574-54-4, represents a significant advancement in the field of medicinal chemistry and pharmacological research. This heterocyclic compound belongs to the triazine family, a class of molecules known for their diverse biological activities and structural versatility. The presence of both amino and bromo substituents, coupled with a thiophene moiety, endows this molecule with unique chemical properties that make it a promising candidate for further exploration in drug discovery and therapeutic applications.

Recent studies have highlighted the potential of triazine derivatives in addressing various therapeutic challenges. The structural framework of 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)- allows for selective interactions with biological targets, making it an attractive scaffold for designing novel pharmacological agents. The incorporation of a thiophene ring enhances its binding affinity and metabolic stability, which are critical factors in the development of effective drugs.

In the realm of medicinal chemistry, the synthesis and characterization of this compound have been the focus of several innovative research endeavors. The 6-amino group at the 6-position of the triazine ring provides a site for further functionalization, enabling the creation of derivatives with tailored biological properties. This flexibility is particularly valuable in medicinal chemistry, where precise molecular modifications can significantly influence pharmacokinetic and pharmacodynamic profiles.

The 5-bromo-2-thienyl substituent at the 4-position introduces additional complexity to the molecule's structure. Thiophene derivatives are well-documented for their role in various biological processes, including anti-inflammatory, antimicrobial, and anticancer activities. The bromine atom further enhances the compound's reactivity, allowing for diverse chemical transformations that can be exploited in drug development.

One of the most compelling aspects of 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)- is its potential as a lead compound for therapeutic intervention. Preclinical studies have begun to explore its efficacy in models relevant to human diseases. For instance, preliminary investigations suggest that this compound may exhibit inhibitory effects on certain enzymes and receptors implicated in inflammatory and degenerative conditions. These findings are particularly intriguing given the growing interest in targeted therapies that modulate specific biological pathways.

The synthesis of 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)- involves multi-step organic reactions that highlight the ingenuity of modern synthetic methodologies. The process typically begins with the formation of a triazine core through condensation reactions between appropriate precursors. Subsequent functionalization steps introduce the amino group at the 6-position and the bromo-substituted thiophene moiety at the 4-position. These synthetic routes underscore the importance of well-designed synthetic strategies in generating complex molecules with desired properties.

In terms of physicochemical properties, 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)- exhibits characteristics that make it suitable for further development as a pharmaceutical agent. Its solubility profile allows for easy formulation into various delivery systems, while its stability under different conditions ensures compatibility with storage and transportation requirements. These attributes are crucial for ensuring that the compound remains effective throughout its intended use.

The potential applications of this compound extend beyond traditional therapeutic areas. Researchers are also exploring its utility in agrochemicals and material science due to its structural features and reactivity. For instance, derivatives of this molecule may serve as intermediates in synthesizing novel pesticides or as components in advanced materials with specific electronic properties.

As our understanding of biological systems continues to evolve, so too does our ability to design molecules that interact selectively with disease-causing targets. The case of 1,3,5-Triazin-2(1H)-one, 6-amino-4-(5-bromo-2-thienyl)- exemplifies how structural modifications can unlock new therapeutic possibilities. By leveraging cutting-edge synthetic techniques and computational methods to analyze molecular interactions, scientists are paving the way for more effective and personalized treatments.

The future prospects for this compound remain promising as ongoing research delves deeper into its mechanisms of action and potential applications. Collaborative efforts between academic institutions and pharmaceutical companies will be essential in translating these findings into tangible benefits for patients worldwide. The journey from laboratory discovery to clinical application is long and complex but holds immense potential for improving human health.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)